½ÃÀ庸°í¼­
»óǰÄÚµå
1750640

ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÄÝ Æ÷ÀÎÆ®º°, Á¦Ç° À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Disposable Blood Pressure Cuffs Market Size, Share & Trends Analysis Report By Call Point, By Product Type, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 110 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 6¾ï 8,460¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â°£ ¿¬Æò±Õ 12.53%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°íÇ÷¾Ð, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ºó¹øÇÑ Ç÷¾Ð ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ç°­°ú ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÏȸ¿ë Ç÷¾Ð°è¸¦ Æ÷ÇÔÇÑ ÀÏȸ¿ë ÀÇ·á±â±âÀÇ Ã¤ÅÃÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¿ÇÁ´Â À§»ýÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÌ¸ç Æí¸®ÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ÀÓ»ó ÇöÀå¿¡¼­ÀÇ °¨¿° À§ÇèÀ» ÁÙÀÔ´Ï´Ù.

¿Ü°ú¼ö¼ú°ú ÁßȯÀÚ½Ç ÀÔ¿øÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤È®ÇÏ°í ¾ÈÀüÇÑ È¯ÀÚ ¸ð´ÏÅ͸µÀ» À§ÇØ ÀÏȸ¿ë Ç÷¾Ð Ä¿ÇÁÀÇ »ç¿ëÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¿ÇÁ´Â ÁßȯÀÚ½Ç È¯°æ¿¡¼­ ¸Å¿ì Áß¿äÇÑ ÀÌÂ÷ ¿À¿°ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ³ëÈ­ °ü·Ã ÁúȯÀ¸·Î ÀÎÇØ ÀæÀº °Ç°­ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇØÁö¸é¼­ ÀÏȸ¿ë Ç÷¾Ð°è¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¼ö¼ú Áõ°¡¿Í °í·ÉÈ­ Àα¸ÃþÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ÄÝ Æ÷ÀÎÆ®º°·Î´Â ÀÇ»ç ºÎ¹®ÀÌ 2024³â 45.7%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇϸç, ÀÓ»ó ȯ°æ¿¡¼­ Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç À§»ýÀûÀÎ ¸ð´ÏÅ͸µ Åø¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¿¡ ÈûÀÔ¾î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • ¿Ü·¡ ȯÀÚ ¸ð´ÏÅ͸µ°ú °Ç°­ ¹®Á¦ Á¶±â ¹ß°ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÓ»óÀÇ ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ¼ºÀοë ÀÏȸ¿ë Ç÷¾Ð°è ºÎ¹®Àº 2024³â °¡Àå Å« ½ÃÀå ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â ¼ºÀÎÀÇ °íÇ÷¾Ð ¹× ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ºó¹øÇϰí Á¤È®ÇÑ Ç÷¾Ð ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù.
  • ½Å»ý¾Æ ÀÏȸ¿ë Ç÷¾Ð°è ºÎ¹®Àº 2025-2030³â µ¿¾È °¡Àå ºü¸¥ CAGR·Î È®À뵃 °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ºÏ¹Ì´Â 2024³â 36.0%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇϸç, ÀÌ Áö¿ªÀÇ Ã·´ÜÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº °íÇ÷¾Ð À¯º´·ü, °Ç°­ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ³ôÀº ÀνĿ¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ À̾ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ºÐ¼® Åø
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : ÄÝ Æ÷ÀÎÆ®º°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÄÝ Æ÷ÀÎÆ® ºÎ¹® ´ë½Ãº¸µå
  • ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : ÄÝ Æ÷ÀÎÆ® º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(ÄÝ Æ÷ÀÎÆ®º°, 2018-2030³â)
  • ³»°úÀÇ
  • ÀÓ»óÀÇ
  • ¿Ü°úÀÇ

Á¦5Àå ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : Á¦Ç° À¯Çüº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Á¦Ç° À¯Çü ºÎ¹® ´ë½Ãº¸µå
  • ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : Á¦Ç° À¯Çü º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(Á¦Ç° À¯Çüº°, 2018-2030³â)
  • ½Å»ý¾Æ¿ë ÀÏȸ¿ë Ç÷¾Ð°è
  • ¼ºÀοë ÀÏȸ¿ë Ç÷¾Ð°è

Á¦6Àå ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ÀÏȸ¿ë Ç÷¾Ð°è ½ÃÀå : ÁÖ¿ä Æ÷ÀÎÆ®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀï ºÐ·ù
  • º¥´õ ±¸µµ
    • ÁÖ¿ä ±â¾÷ È÷Æ®¸Ê ºÐ¼®, 2024³â
  • ±â¾÷ °³¿ä
    • GE HealthCare
    • Koninklijke Philips NV
    • SunTech Medical, Inc.
    • OMRON Healthcare, Inc.
    • American Diagnostic Corporation
    • Hillrom(Baxter)
    • Spacelabs Healthcare(OSI Systems, Inc.)
    • Midmark Corporation
    • Cardinal Health
    • Medline Industries, Inc.
KSA 25.06.25

Disposable Blood Pressure Cuffs Market Growth & Trends:

The global disposable blood pressure cuffs market size is anticipated to reach USD 684.6 million by 2030 and projected to grow at a CAGR of 12.53% from 2025 to 2030, according to a new report by Grand View Research, Inc.The rising incidence of chronic diseases, such as hypertension and diabetes, is driving the demand for frequent blood pressure monitoring. Increased awareness about health and safety has led to a surge in the adoption of single-use medical devices, including disposable blood pressure cuffs. These cuffs offer a hygienic, cost-effective, convenient solution, reducing the risk of infection in clinical settings.

The rising number of surgical procedures and increasing ICU admissions necessitate the use of disposable blood pressure cuffs for accurate and safe patient monitoring. These cuffs minimize the risk of cross-contamination, which is crucial in critical care settings. In addition, the growing elderly population, which requires more frequent health monitoring due to age-related conditions, further drives the demand for disposable blood pressure cuffs. Hence, an increase in surgeries and an aging demographic are expected to drive market growth.

Disposable Blood Pressure Cuffs Market Report Highlights:

  • Based on call point, the physicians segment led the market with the largest revenue share of 45.7% in 2024, fueled by the high demand for accurate, reliable, and hygienic monitoring tools in clinical settings.
  • The clinicians segment is projected to grow at the fastest CAGR during the forecast period, driven by the increasing emphasis on outpatient monitoring and early detection of health issues.
  • The adult disposable blood pressure cuffs segment accounted for the largest market revenue share in 2024, attributed to the high prevalence of hypertension and cardiovascular diseases among adults, necessitating frequent and accurate blood pressure monitoring.
  • The neonate disposable blood pressure cuffs segment is anticipated to witness at the fastest CAGR from 2025 to 2030, due to the increasing number of preterm births globally, which necessitates specialized monitoring tools for newborns.
  • North America dominated the market with the largest revenue share of 36.0% in 2024, propelled bythe region's advanced healthcare infrastructure, high prevalence of hypertension, and strong consumer awareness about health monitoring.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Call Point
    • 1.2.2. Product Type
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Call Point Outlook
    • 2.2.2. Product Type Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Disposable Blood Pressure Cuffs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Disposable Blood Pressure Cuffs Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Disposable Blood Pressure Cuffs Market: Call Point Estimates & Trend Analysis

  • 4.1. Call Point Segment Dashboard
  • 4.2. Disposable Blood Pressure Cuffs Market: Call Point Movement Analysis
  • 4.3. Global Disposable Blood Pressure Cuffs Market Size & Trend Analysis, By Call Point, 2018 to 2030 (USD Million)
  • 4.4. Physicians
    • 4.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5. Clinicians
    • 4.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.6. Surgeons
    • 4.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Disposable Blood Pressure Cuffs Market: Product Type Estimates & Trend Analysis

  • 5.1. Product Type Segment Dashboard
  • 5.2. Disposable Blood Pressure Cuffs Market: Product Type Movement Analysis
  • 5.3. Global Disposable Blood Pressure Cuffs Market Size & Trend Analysis, By Product Type, 2018 to 2030 (USD Million)
  • 5.4. Neonate Disposable Blood Pressure Cuffs
    • 5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.5. Adult Disposable Blood Pressure Cuffs
    • 5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Disposable Blood Pressure Cuffs Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Disposable Blood Pressure Cuffs Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/ Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. GE HealthCare
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Koninklijke Philips N.V.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. SunTech Medical, Inc.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. OMRON Healthcare, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. American Diagnostic Corporation
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Hillrom (Baxter)
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Spacelabs Healthcare (OSI Systems, Inc.)
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Midmark Corporation
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cardinal Health
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Medline Industries, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦